Chinese COVID-19 Vaccines Under Spotlight After Woman Censored for Posting About Death Following Sinopharm Shot

The censoring of a woman who posted about the death of her mother after receiving a COVID-19 vaccine has recently caused a stir in China, prompting further scrutiny on the effectiveness of Chinese-made vaccines.

"China has projected deep confidence in its vaccines and has used it to bolster its international reputation and the trust of the Chinese public. It is using all the means of state control and censorship to defend its vaccines and vaccine diplomacy," Lawrence Gostin, professor of Global Health Law at Georgetown University, told The Epoch Times in an email.

He said that most people in China had no way of obtaining accurate information on the effectiveness of Chinese-made vaccines, "The CCP can continue to claim the superiority of Chinese vaccines in China without any challenges. However, it remains to be seen how effective is the CCP's propaganda of made-in-China vaccines around the world."

A recent study by the kingdom of Bahrain and Columbia University researchers found that the recipients of the Sinopharm vaccine had significantly higher rates of hospitalization, ICU admission, and death compared to other vaccines, especially among those aged 50 or older.

The death rate of post-vaccination positive cases in the population 18 years and older is three times for Sinopharm vaccines than for Pfizer-BioNTech, it found.

"From what we know, its vaccines are not nearly as effective as Western vaccines, especially against the Delta variant."

China's National Health Commission announced on Sept. 1 that as of Aug. 31, mainland Chinese provinces had received a total of two billion doses of COVID-19 vaccines.

https://www.theepochtimes.com/chinese-covid-19-vaccines-under-spotlight-after-woman-censored-for-posting-about-death-following-sinopharm-shot_3977699.html